publication . Other literature type . Article . 2013

Anti-cancer activities of Ganoderma lucidum: active ingredients and pathways

Chi H.J. Kao; Amalini C. Jesuthasan; Karen S. Bishop; Marcus P. Glucina; Lynnette R. Ferguson;
Open Access
  • Published: 09 Feb 2013
  • Publisher: Functional Food Center
<jats:p>Ganoderma lucidum, commonly referred to as Lingzhi, has been used in Asia for health promotion for centuries. The anti-cancer effects of G. lucidum have been demonstrated in both in vitro and in vivo studies. In addition, the observed anti-cancer activities of Ganoderma have prompted its usage by cancer patients alongside chemotherapy. The main two bioactive components of G. lucidum can be broadly grouped into triterpenes and polysaccharides. Despite triterpenes and polysaccharides being widely known as the major active ingredients, the different biological pathways by which they exert their anti-cancer effect remain poorly defined. Therefore, understand...
free text keywords: Ganoderma lucidum, cancer, bioactive pathways, triterpene, polysaccharide, Nutrition. Foods and food supply, TX341-641, Medicine (General), R5-920
Related Organizations
101 references, page 1 of 7

1. Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS: Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 2009, 10(8):717-742.

2. Mau JL, Lin HC, Chen CC: Non-volatile components of several medicinal mushrooms. Food Research International. 2001, 34(6):521-526.

3. Boh B, Berovic M, Zhang J, Zhi-Bin L: Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev. 2007, 13:265-301.

4. Zhou XW, Lin J, Yin YZ, Zhao JY, Sun XF, Tang KX: Ganodermataceae: Natural products and their related pharmacological functions. American Journal of Chinese Medicine. 2007, 35(4):559-574.

5. Yuen JW, Gohel MD: Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer. 2005, 53(1):11-17.

6. Shi L, Ren A, Mu D, Zhao M: Current progress in the study on biosynthesis and regulation of ganoderic acids. Appl Microbiol Biotechnol. 2010, 88(6):1243-1251.

7. Haralampidis K, Trojanowska M, Osbourn AE: Biosynthesis of triterpenoid saponins in plants. Adv Biochem Eng Biotechnol. 2002, 75:31-49.

8. Yue QX, Song XY, Ma C, Feng LX, Guan SH, Wu WY, Yang M, Jiang BH, Liu X, Cui YJ, Guo DA: Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2010, 17(8-9):606-613.

9. Su CH, Yang YZ, Ho HO, Hu CH, Sheu MT: High-performance liquid chromatographic analysis for the characterization of triterpenoids from Ganoderma. J Chromatogr Sci. 2001, 39(3):93-100.

10. Chen NH, Liu JW, Zhong JJ: Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacol Rep. 2010, 62(1):150-163.

11. Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ: Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 2006, 80(3):205-211.

12. Xu K, Liang X, Gao F, Zhong J, Liu J: Antimetastatic effect of ganoderic acid T in vitro through inhibition of cancer cell invasion. Process Biochemistry. 2010, 45(8):1261-1267.

13. Yue QX, Cao ZW, Guan SH, Liu XH, Tao L, Wu WY, Li YX, Yang PY, Liu X, Guo DA: Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics. 2008, 7(5):949-961.

14. Chang UM, Li CH, Lin LI, Huang CP, Kan LS, Lin SB: Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life sciences. 2006, 79(12):1129-1139.

15. Min BS, Gao JJ, Nakamura N, Hattori M: Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chemical & pharmaceutical bulletin. 2000, 48(7):1026-1033.

101 references, page 1 of 7
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue